If you watched the 2026 FIFA World Cup, you have probably seen Ascend Sport's work. The advertising boards around the field were digital, and Ascend is the company behind that technology.
Now Ascend wants to go public, and it found an unusual shortcut. EvoNext Holdings SA already trades on the SIX Swiss Exchange, but it's a shell - basically an empty company with a stock listing.
Ascend would merge into it, and Ascend's owners would take control of the listed company. That arrangement is called a reverse merger.
Companies use reverse mergers when they want a stock market listing without going through a traditional initial public offering, which takes longer and costs more. Reverse mergers have a mixed reputation.
They are faster and cheaper than an IPO, but they also come with less public scrutiny. EvoNext's shares would be priced at about 2.50 francs each as part of the proposed transaction. But nothing is signed yet.
Ascend is also considering selling significant minority stakes to private equity firms, or increasing stakes for its existing minority holders, so the deal could go in a few different directions.
The best financial decisions come from understanding the whole picture. Join Market Briefs free and get the full brief each morning.
Ascend is based in Kriens, Switzerland, and its business is sports marketing and digital advertising. It works on the advertising boards that ring soccer fields, turning them into digital displays.
Perimeter boards are the low walls around the field, and brands use them to reach fans watching on TV. The technology was used at the 2026 FIFA World Cup, and its clients include AIM Sport.
That kind of real-world track record is what makes a company attractive to public market investors. It is one thing to pitch a product, and another thing to show it working on the biggest stage in soccer.
EvoNext is what remains of a Swiss company that once used fermentation and biotechnology to create ingredients for the food and pharmaceutical industries. The company had planned to sign its operating business to Danstar Ferment AG, which is part of Lallemand Inc., with the transfer expected to close toward the end of 2023. Earlier this year it said it was actively seeking strategic options with a focus on reverse mergers. That means Ascend is exactly the kind of deal EvoNext has been hunting for.
The market clearly likes the idea. The jump came after a statement on August 17, 2026 disclosed the talks. The stock closed above the proposed deal price of 2.50 francs, a sign that investors see a real chance the merger goes through.
A 33% move is a big deal for any available token, and it tells you how much room a shell company has to run on deal news. It also cuts both ways, since a failed deal could send the stock right back down.
For investors, the key thing to watch is whether a binding deal actually gets done. Reverse mergers can unravel, and Ascend has other options on the table.
If the deal goes through, EvoNext shareholders would be getting a company valued at up to 600 million francs for shares priced at 2.50 francs each. If it doesn't, the stock could give back those gains just as fast.
The other thing to watch is which path Ascend picks. A private equity deal would keep the company private, while a reverse merger would put it on the public market, and those are very different outcomes for anyone holding EvoNext shares.
A stock that jumps 33% on deal news is pricing in a lot of hope. Ascend has a serious business with real clients, but the deal itself is still just a proposal.
Markets move every day, and most of it never reaches you in time. Get the free Market Briefs daily newsletter and stay ahead of it.
